Avrobio Company

Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.

Estimated Revenue: $10M to $50M
Funding Status: IPO
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2015
Technology: Cancer
Industry: Gene Therapy